rs146655995
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001271.4(CHD2):c.4078G>A(p.Gly1360Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000465 in 1,613,778 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1360E) has been classified as Uncertain significance.
Frequency
Consequence
NM_001271.4 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy 94Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Lennox-Gastaut syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myoclonic-astatic epilepsyInheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CHD2 | NM_001271.4 | c.4078G>A | p.Gly1360Arg | missense_variant | Exon 32 of 39 | ENST00000394196.9 | NP_001262.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000269 AC: 41AN: 152202Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000557 AC: 14AN: 251340 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461458Hom.: 0 Cov.: 30 AF XY: 0.0000206 AC XY: 15AN XY: 727048 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000269 AC: 41AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.000362 AC XY: 27AN XY: 74492 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
Developmental and epileptic encephalopathy 94 Benign:2
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at